2848
X. Han / Tetrahedron Letters 48 (2007) 2845–2849
of the presence of b-ArS moiety.13 When alkynol 6 was
treated with DBU under the standard procedure but
without any nucleophiles, isomerized product 5 was
formed in 50% yield. This reaction provided easy access
to this class of compounds exemplified by compound 36,
which was prepared previously via a much longer reac-
tion sequence.14
13
12
11
10
18
8
3
9
N
7
O
4
N
15
1
14
O
6
16
17
2
5
O
5
9
OH
SH
OH
standard
Ph
CO2Et
(126 MHz, CDCl3) d ppm 196.43 (C4), 169.21 (C1),
152.26 (C9), 137.47 (C12), 136.39 (C14), 133.64 (C17),
131.82 (C7), 130.78 (C18), 129.27 (C16), 128.76 (C11),
128.33 (C15), 125.77 (C10), 103.13 (C8), 62.15 (C5),
60.01 (C2), 40.59 (C3), 21.31 (C13), 14.09 (C6). LRMS
363.18 (MH+), calcd for C22H22N2O3 362.16.
+
Ph
procedure
84% yield
S
(3)
CO2Et
OMe
OMe
6
36
I believe that the reactions proceeded via two steps, re-
dox isomerization followed by conjugate addition.
DBU was required for the first step as well as the conju-
gate addition step. This one-pot process provided prod-
ucts more conveniently and in higher yields than the
discrete two step process, probably due to the in situ for-
mation of trans-4-aryl-4-oxobut-2-enoate, which is not
very stable in the presence of DBU.
Acknowledgements
I thank Drs. John Macor and Gene Dubowchik for their
constant support during the course of this study and
their critical reading of the manuscript and Dr. Yingzi
Wang for assistance in 2D NMR analysis of compound
9.
In conclusion, a practical and expedient synthesis of 2-
heterocycle (C–N bond) substituted 4-oxo-4-arylbutano-
ates was described. The simplicity of the procedure and
its applicability to a wide variety of diverse NH-contain-
ing heterocycles are key features of this procedure. Be-
cause two equivalents of heterocycles was used in the
reaction and there was <20% of conversion when pyri-
dine was used as the base, this general procedure shall
find wider applications in reactions involving more com-
plex starting materials, such as 4-heteroaryl-4-hydroxy-
2,3-alkynyl esters, whose products could be of interest
as potential drug targets.
Supplementary data
1H, 13C NMR (data and spectra) and LRMS data for all
compounds, structural determinations (by COSY,
DEPT, HMQC, HMBC, and 1D NOE) of all applicable
compounds. Supplementary data associated with this
article can be found, in the online version, at
References and notes
Experimental
1. (a) Analogue-based Drug Discovery; Fischer, J., Ganellin,
C. R., Eds.; Wiley-VCH: Weinheim, Germany, 2006; (b)
Li, J.-J.; Johnson, D. S.; Sliskovic, D. R.; Roth, B. D.
General procedure for the formation of 2-heterocycle
(C–N bond) substituted 4-oxo-4-arylbutanoates.
Preparation of 9
Contemporary Drug Synthesis; John Wiley
& Sons:
Hoboken, New Jersey, 2004.
´
2. Me4NF: (a) Menand, M.; Dalla, V. Synlett 2005, 95–98;
KF/Al2O3: (b) Yang, L.; Xu, L.-W.; Xia, C.-G. Tetra-
hedron Lett. 2005, 46, 3279–3282; PPh3/TMSCl: (c) Xu,
L.-W.; Xia, C.-G. Tetrahedron Lett. 2004, 45, 4507–4510;
CeCl3Æ7H2O/NaI/Al2O3: (d) Bartoli, G.; Bartolacci, M.;
Giuliani, A.; Marcantoni, E.; Massaccesi, M.; Torregiani,
E. J. Org. Chem. 2005, 70, 169–174; RhCl3Æ3H2O or
PdCl2(MeCN)2/TMSCl: (e) Xu, L.-W.; Xia, C.-G. Syn-
thesis 2004, 2191–2195; Bi(NO3)3: (f) Srivastava, N.;
Banik, B. K. J. Org. Chem. 2003, 68, 2109–2114; FeCl3/
TMSCl: (g) Xu, L.-W.; Xia, C.-G.; Hu, X.-X. Chem.
Commun. 2003, 2570–2571; BF3ÆOEt2/Bu4NBr: (h) Xu, L.-
W.; Li, L.; Xia, C.-G.; Zhou, S.-L.; Li, J.-W.; Hu, X.-X.
Synlett 2003, 2337–2340; Cu(OTf)2 (i) Wabnitz, T. C.;
Spencer, J. B. Tetrahedron Lett. 2002, 43, 3891–3894;
PtCl4Æ5H2O and other transition metal salts: (j) Koba-
yashi, S.; Kakumoto, K.; Sugiura, M. Org. Lett. 2002, 4,
1319–1322.
1,8-Diazabicyclo(5.4.0)undec-7-ene (DBU, 0.164 mL,
1.100 mmol) was added drop-wise at rt to the solution
of ethyl 4-hydroxy-4-phenylbut-2-ynoate (0.204 g,
1 mmol) and 3-p-tolyl-1H-pyrazole (0.316 g, 2.000
mmol) in CH2Cl2 (5 mL). The mixture was stirred at rt
for 16 h and it was poured onto a silica gel column.
Flash chromatography eluenting with EA/hexanes
(1:7) afforded ethyl 2-(3-phenyl-2-(3-p-tolyl-1H-pyr-
azol-1-yl)oxiran-2-yl)acetate (0.254 g, 0.700 mmol, 70%
yield) as an off-white solid. 1H NMR (500 MHz, CDCl3)
d ppm 7.98–8.02 (m, 2H, H15), 7.66 (d, J = 7.93 Hz, 2H,
H10), 7.61 (d, J = 2.44 Hz, 1H, H7), 7.57 (t, J =
7.32 Hz, 1H, H17), 7.46 (t, J = 7.78 Hz, 2H, H16),
7.17 (d, J = 7.90 Hz, 2H, H11), 6.53 (d, J = 2.44 Hz,
1H, H8), 5.63 (t, J = 6.41 Hz, 1H, H2), 4.23 (q, J =
7.12 Hz, 2H, H5), 4.07 (dd, J = 18.0, 6.41 Hz, 1H,
H3), 3.96 (dd, J = 18.0, 6.72 Hz, 1H, H3), 2.35 (s, 3H,
H13), 1.22 (t, J = 7.17 Hz, 3H, H6). 13C NMR
3. Ionic liquid: (a) Yang, L.; Xu, L.-W.; Zhou, W.; Li, L.;
Xia, C.-G. Tetrahedron Lett. 2006, 47, 7723–7726;
DBACO/TBAB (Bu4NBr)/microwave: (b) Khalafi-Nez-